FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Updates Alert on Halyard N95 Masks

FDA provides further clarification about a safety alert issued earlier this year that recommended against the use of certain surgical N95 respirators ...

latest-news-card-1
Federal Register

Endogenous Cushings Syndrome Guidance

Federal Register notice: FDA makes available a draft guidance entitled Endogenous Cushings Syndrome: Developing Drugs for Treatment.

latest-news-card-1
Federal Register

Guide on ISO 10993-1 Biological Evaluations

Federal Register notice: FDA posts a final guidance entitled Use of International Standard ISO 109931, Biological Evaluation of Medical Devices Part ...

latest-news-card-1
Federal Register

Combo Product Human Factors Guide

Federal Register notice: FDA makes available a final guidance entitled Application of Human Factors Engineering (HFE) Principles for Combination Produ...

latest-news-card-1
Human Drugs

Senators Reintroduce Opioid Studies Bill

U.S. Senators Joe Manchin (D-WV) and Mike Braun (R-IN) reintroduce their bipartisan FDA Review of Efficacy EERW Double-Blinds (FREED) of Opioids Act.

latest-news-card-1
Human Drugs

House Committee Hearing on Drug Shortages

The House Energy and Commerce Committee announces a 9/14 legislative hearing to discuss legislative proposals on preventing generic drug shortages.

latest-news-card-1
Human Drugs

IRB Review of Expanded Access Request Guide

FDA posts a guidance entitled Institutional Review Board (IRB) Review of Individual Patient Expanded Access Submissions for Investigational Drugs and ...

latest-news-card-1
Human Drugs

Subcutaneous Tecentrig Delayed Due to CMC Info

FDA requests updated chemistry, manufacturing and controls information on Genentechs subcutaneous formulation of lung cancer drug Tecentriq (atezolizu...

latest-news-card-1
Medical Devices

GAO Report Probes Device DTC Advertising

In what is a likely sign of increasing interest on Capitol Hill, the Government Accountability Office releases a new report examining FDA and FTC over...

latest-news-card-1
Federal Register

Panel to Review Merck Cough Drug

Federal Register notice: FDA announces an 11/17 Pulmonary-Allergy Drugs Advisory Committee to review a Merck NDA for gefapixant oral tablets.